4-oxo-piperidine-1-carboxylic acid phenyl ester | 41979-37-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: 4-oxo-piperidine-1-carboxylic acid phenyl ester
• 英文别名: 1-(phenoxycarbonyl)piperidone；1-benzoyl-4-piperidinone；phenyl 4-oxopiperidine-1-carboxylate；1-Carbophenoxy-4-piperidon
• CAS: 41979-37-7
• 化学式: C₁₂H₁₃NO₃
• mdl: MFCD08694956
• 分子量: 219.24
• InChiKey: GAHCFHFEQNHEFO-UHFFFAOYSA-N

物化性质

• 沸点：
  363.3±42.0 °C(Predicted)
• 密度：
  1.237±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.333
• 拓扑面积：
  46.6
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  4-oxo-piperidine-1-carboxylic acid phenyl ester 在 氢氧化钾 、 对甲苯磺酸 作用下， 以 水 、 甲苯 为溶剂， 反应 30.0h， 生成 4-哌啶酮缩乙二醇
  参考文献：
  名称：

  Mauleon; Antunez; Rosell, Il Farmaco, 1989, vol. 44, # 11, p. 1109 - 1117

  摘要：

  DOI：
• 作为产物：
  描述：

  4,4-亚乙二氧基-1-(苯氧基羰基)哌啶 在 indium(III) triflate 作用下， 以 丙酮 为溶剂， 反应 0.33h， 以58%的产率得到4-oxo-piperidine-1-carboxylic acid phenyl ester
  参考文献：
  名称：

  [EN] THIENOPYRIMIDINE AS CDC7 KINASE INHIBITORS
  [FR] THIÉNOPYRIMIDINES EN TANT QU'INHIBITEURS DE LA KINASE CDC7

  摘要：

  本发明涉及一种由式(I)表示的化合物，其中每个符号如规范中定义，或其盐，或其前药，用于预防或治疗癌症。

  公开号：

  WO2010101302A1

文献信息

• SUBSTITUTED PIPERIDINES AS CCR3 ANTAGONISTS
  申请人：GRUNDL Marc

  公开号：US20100261687A1

  公开（公告）日：2010-10-14

  Object of the present invention are novel substituted compounds of the formula 1, wherein A, R 1 , R 2 , R 3 and R 4 are defined as in the description. Another object of the present invention is to provide antagonists of CCR3, more particularly to provide pharmaceutical compositions comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of at least one of the compounds of the present invention or a pharmaceutically acceptable salt thereof.

  本发明的对象是公式1的新型取代化合物，其中A、R1、R2、R3和R4的定义如描述中所述。本发明的另一个对象是提供CCR3的拮抗剂，更具体地提供包含药用可接受载体和本发明化合物中至少一种或其药用可接受盐的治疗有效量的药物组合物。
• THIENOPYRIMIDINE AS CDC7 KINASE INHIBITORS
  申请人：Oguro Yuya

  公开号：US20120040981A1

  公开（公告）日：2012-02-16

  The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof, or a prodrug thereof, which is useful for the prophylaxis or treatment of cancer.

  本发明涉及一种由式(I)所表示的化合物：其中每个符号如规范中定义，或其盐，或其前药，用于癌症的预防或治疗。
• Therapeutic methods employing substituted piperidines which are CCR3 antagonists
  申请人：GRUNDL Marc

  公开号：US20130023517A1

  公开（公告）日：2013-01-24

  Object of the present invention are novel substituted compounds of the formula 1, wherein A, R 1 , R 2 , R 3 and R 4 are defined as in the description. Another object of the present invention is to provide antagonists of CCR3, more particularly to provide pharmaceutical compositions comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of at least one of the compounds of the present invention or a pharmaceutically acceptable salt thereof.

  本发明的目的是提供公式1的新型取代化合物，其中A、R1、R2、R3和R4的定义如描述中所述。本发明的另一个目的是提供CCR3的拮抗剂，更具体地提供包含药学上可接受的载体和本发明化合物中至少一种或其药学上可接受的盐的治疗有效量的制药组合物。
• Thienopyrimidine as CDC7 kinase inhibitors
  申请人：Oguro Yuya

  公开号：US08691828B2

  公开（公告）日：2014-04-08

  The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof, or a prodrug thereof, which is useful for the prophylaxis or treatment of cancer.

  本发明涉及一种由公式（I）表示的化合物：其中每个符号如规范中所定义，或其盐，或其前药，用于预防或治疗癌症。
• Synthesis and biological evaluation of 2-amino-3-(3′,4′,5′-trimethoxybenzoyl)-6-substituted-4,5,6,7-tetrahydrothieno[2,3-c]pyridine derivatives as antimitotic agents and inhibitors of tubulin polymerization
  作者：Romeo Romagnoli、Pier Giovanni Baraldi、Maria Dora Carrion、Olga Cruz-Lopez、Carlota Lopez Cara、Manlio Tolomeo、Stefania Grimaudo、Antonietta Di Cristina、Maria Rosa Pipitone、Jan Balzarini、Sahar Kandil、Andrea Brancale、Taradas Sarkar、Ernest Hamel

  DOI：10.1016/j.bmcl.2008.08.006

  日期：2008.9

  Microtubules are among the most successful targets of compounds potentially useful for cancer therapy. A new series of inhibitors of tubulin polymerization based on the 2-amino-3-(3,4,5-trimethoxybenzoyl)-4,5,6,7-tetrahydrothieno[b]pyridine molecular skeleton was synthesized and evaluated for antiproliferative activity, inhibition of tubulin polymerization, and cell cycle effects. The most promising compound in this series was 2-amino-3-(3,4,5-trimethoxybenzoyl)-6-methoxycarbonyl-4,5,6,7-tetrahydrothieno[b]pyridine, which inhibits cancer cell growth with IC50-values ranging from 25 to 90 nM against a panel of four cancer cell lines, and interacts strongly with tubulin by binding to the colchicine site. In this series of N-6-carbamate derivatives, any further increase in the length and in the size of the alkyl chain resulted in reduced activity. (C) 2008 Elsevier Ltd. All rights reserved.